Format
Sort by
Items per page

Send to

Choose Destination

Links from MedGen

Items: 1 to 20 of 112

1.

Homozygous loss of menin is well tolerated in liver, a tissue not affected in MEN1.

Scacheri PC, Crabtree JS, Kennedy AL, Swain GP, Ward JM, Marx SJ, Spiegel AM, Collins FS.

Mamm Genome. 2004 Nov;15(11):872-7.

PMID:
15672591
2.
3.

Novel intronic mutation of MEN1 gene causing familial isolated primary hyperparathyroidism.

Carrasco CA, González AA, Carvajal CA, Campusano C, Oestreicher E, Arteaga E, Wohllk N, Fardella CE.

J Clin Endocrinol Metab. 2004 Aug;89(8):4124-9.

PMID:
15292357
4.

Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma.

Hao W, Skarulis MC, Simonds WF, Weinstein LS, Agarwal SK, Mateo C, James-Newton L, Hobbs GR, Gibril F, Jensen RT, Marx SJ.

J Clin Endocrinol Metab. 2004 Aug;89(8):3776-84.

PMID:
15292304
5.

Unusual presentation of multiple endocrine neoplasia type 1 in a young woman with a novel mutation of the MEN1 gene.

Balogh K, Patócs A, Majnik J, Varga F, Illyés G, Hunyady L, Rácz K.

J Hum Genet. 2004;49(7):380-6. Epub 2004 Jun 16.

PMID:
15205994
6.

THE ZOLLINGER-ELLISON SYNDROME: RE-APPRAISAL AND EVALUATION OF 260 REGISTERED CASES.

ELLISON EH, WILSON SD.

Ann Surg. 1964 Sep;160:512-30. No abstract available.

7.

FAMILIAL MULTIPLE ENDOCRINE ADENOMA-PEPTIC ULCER COMPLEX.

BALLARD HS, FAME B, HARTSOCK RJ.

Medicine (Baltimore). 1964 Jul;43:481-516. No abstract available.

PMID:
14183520
8.

FAMILIAL HYPERPARATHYROIDISM. A KINDRED INVOLVING ELEVEN CASES, WITH A DISCUSSION OF PRIMARY CHIEF-CELL HYPERPLASIA.

CUTLER RE, REISS E, ACKERMAN LV.

N Engl J Med. 1964 Apr 23;270:859-65. No abstract available.

PMID:
14110030
9.

FAMILIAL ENDOCRINE ADENOMATOSIS. A FAMILY WITH HYPERINSULINISM AS THE PREDOMINANT MANIFESTATION.

UNDERWOOD LE, JACOBS NM.

Am J Dis Child. 1963 Aug;106:218-23. No abstract available.

PMID:
14056823
10.

The association of bronchial carcinoid and pluriglandular adenomatosis.

WILLIAMS ED, CELESTIN LR.

Thorax. 1962 Jun;17:120-7. No abstract available.

11.

Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas.

ZOLLINGER RM, ELLISON EH.

Ann Surg. 1955 Oct;142(4):709-23; discussion, 724-8. No abstract available.

12.

Genetic aspects of adenomatosis of endocrine glands.

WERMER P.

Am J Med. 1954 Mar;16(3):363-71. No abstract available.

PMID:
13138607
13.

Transcription regulation of the multiple endocrine neoplasia type 1 gene in human and mouse.

Zablewska B, Bylund L, Mandic SA, Fromaget M, Gaudray P, Weber G.

J Clin Endocrinol Metab. 2003 Aug;88(8):3845-51.

PMID:
12915678
14.

Multiple tumor suppressor pathways negatively regulate telomerase.

Lin SY, Elledge SJ.

Cell. 2003 Jun 27;113(7):881-9.

15.

Germline mutations of the MEN1 gene in Korean families with multiple endocrine neoplasia type 1 (MEN1) or MEN1-related disorders.

Park JH, Kim IJ, Kang HC, Lee SH, Shin Y, Kim KH, Lim SB, Kang SB, Lee K, Kim SY, Lee MS, Lee MK, Park JH, Moon SD, Park JG.

Clin Genet. 2003 Jul;64(1):48-53.

PMID:
12791038
16.

A novel six-nucleotide insertion in exon 4 of the MEN1 gene, 878insCTGCAG, in three patients with familial insulinoma and primary hyperparathyroidism.

Okamoto H, Tamada A, Hai N, Doi M, Uchimura I, Hirata Y, Kosugi S.

Jpn J Clin Oncol. 2002 Sep;32(9):368-70.

PMID:
12417605
17.

Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein.

Wautot V, Vercherat C, Lespinasse J, Chambe B, Lenoir GM, Zhang CX, Porchet N, Cordier M, Béroud C, Calender A.

Hum Mutat. 2002 Jul;20(1):35-47.

PMID:
12112656
18.

Frequent occurrence of an intron 4 mutation in multiple endocrine neoplasia type 1.

Turner JJ, Leotlela PD, Pannett AA, Forbes SA, Bassett JH, Harding B, Christie PT, Bowen-Jones D, Ellard S, Hattersley A, Jackson CE, Pope R, Quarrell OW, Trembath R, Thakker RV.

J Clin Endocrinol Metab. 2002 Jun;87(6):2688-93.

PMID:
12050235
19.

Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.

Vergès B, Boureille F, Goudet P, Murat A, Beckers A, Sassolas G, Cougard P, Chambe B, Montvernay C, Calender A.

J Clin Endocrinol Metab. 2002 Feb;87(2):457-65.

20.

Guidelines for diagnosis and therapy of MEN type 1 and type 2.

Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA Jr, Marx SJ.

J Clin Endocrinol Metab. 2001 Dec;86(12):5658-71. Review.

PMID:
11739416

Supplemental Content

Support Center